BRCA1 can modulate RNA polymerase II carboxy-terminal domain phosphorylation levels

Molecular and Cellular Biology

Volumn 24, Issue 16, 2004, Pages 6947-6956

  Moisan, Annie ^a   Larochelle, Chantal ^a   Guillemette, Benoît ^a   Gaudreau, Luc ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRCA1 PROTEIN; CYCLIN DEPENDENT KINASE ACTIVATING KINASE; PHOSPHOTRANSFERASE; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; COMPETITIVE INHIBITION; DNA REPLICATION; ENZYME INHIBITION; GENE CONTROL; GENE MUTATION; HUMAN; HUMAN CELL; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BRCA1 PROTEIN; CELL CYCLE; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RNA POLYMERASE II; TRANSCRIPTION FACTOR TFIIH; TRANSCRIPTION FACTORS, TFII;

EID: 3543034594     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.16.6947-6956.2004     Document Type: Article

References (69)

1. Abbott, D. W., M. E. Thompson, C. Robinson-Benion, G. Tomlinson, R. A. Jensen, and J. T. Holt. 1999. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J. Biol. Chem. 274:18808-18812.
2. Akoulitchev, S., T. P. Makela, R. A. Weinberg, and D. Reinberg. 1995. Requirement for TFIIH kinase activity in transcription by RNA polymerase II. Nature 377:557-560.
3. Akoulitchev, S., and D. Reinberg. 1998. The molecular mechanism of mitotic inhibition of TFIIH is mediated by phosphorylation of CDK7. Genes Dev. 12:3541-3550.
4. Anderson, S. F., B. P. Schlegel, T. Nakajima, E. S. Wolpin, and J. D. Parvin. 1998. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat. Genet. 19:254-256.
5. Aprelikova, O., A. J. Pace, B. Fang, B. H. Koller, and E. T. Liu. 2001. BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. J. Biol. Chem. 276:25647-25650.
6. Araujo, S. J., F. Tirode, F. Coin, H. Pospiech, J. E. Syvaoja, M. Stucki, U. Hubscher, J. M. Egly, and R. D. Wood. 2000. Nucleotide excision repair of DNA with recombinant human proteins: definition of the minimal set of factors, active forms of TFIIH, and modulation by CAK. Genes Dev. 14:349-359.
7. Blau, J., H. Xiao, S. McCracken, P. O'Hare, J. Greenblatt, and D. Bentley. 1996. Three functional classes of transcriptional activation domain. Mol. Cell. Biol. 16:2044-2055.
8. Bregman, D. B., R. Halaban, A. J. van Gool, K. A. Henning, E. C. Friedberg, and S. L. Warren. 1996. UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. Proc. Natl. Acad. Sci. USA 93:11586-11590.
9. Busso, D., A. Keriel, B. Sandrock, A. Poterszman, O. Gileadi, and J. M. Egly. 2000. Distinct regions of MAT1 regulate cdk7 kinase and TFIIH transcription activities. J. Biol. Chem. 275:22815-22823.
10. Carey, M., Y. S. Lin, M. R. Green, and M. Ptashne. 1990. A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives. Nature 345:361-364.
11. Carvalho, M. A., B. Billack, E. Chan, T. Worley, C. Cayanan, and A. N. Monteiro. 2002. Mutations in the BRCT domain confer temperature sensitivity to BRCA1 in transcription activation. Cancer Biol. Ther. 1:502-508.
12. Chapman, M. S., and I. M. Verma. 1996. Transcriptional activation by BRCA1. Nature 382:678-679.
13. Chapman, R. D., B. Palancade, A. Lang, O. Bensaude, and D. Eick. 2004. The last CTD repeat of the mammalian RNA polymerase II large subunit is important for its stability. Nucleic Acids Res. 32:35-44.
14. Coin, F., and J. M. Egly. 1998. Ten years of TFIIH. Cold Spring Harbor Symp. Quant. Biol. 63:105-110.
15. Dahmus, M. E. 1996. Phosphorylation of mammalian RNA polymerase II. Methods Enzymol. 273:185-193.
16. Deng, C. X., and S. G. Brodie. 2000. Roles of BRCA1 and its interacting proteins. Bioessays 22:728-737.
17. Dvir, A., J. W. Conaway, and R. C. Conaway. 2001. Mechanism of transcription initiation and promoter escape by RNA polymerase II. Curr. Opin. Genet. Dev. 11:209-214.
18. Feaver, W. J., J. Q. Svejstrup, N. L. Henry, and R. D. Kornberg. 1994. Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell 79:1103-1109.
19. Fisher, R. P., P. Jin, H. M. Chamberlin, and D. O. Morgan. 1995. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 83:47-57.
20. Fong, N., G. Bird, M. Vigneron, and D. L. Bentley. 2003. A 10 residue motif at the C-terminus of the RNA pol II CTD is required for transcription, splicing and 3′ end processing. EMBO J. 22:4274-4282.
21. Garrett, M. D., and A. Fattaey. 1999. CDK inhibition and cancer therapy. Curr. Opin. Genet. Dev. 9:104-111.
22. Garrett, S., W. A. Barton, R. Knights, P. Jin, D. O. Morgan, and R. P. Fisher. 2001. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop. Mol. Cell. Biol. 21:88-99.
23. Haile, D. T., and J. D. Parvin. 1999. Activation of transcription in vitro by the BRCA1 carboxyl-terminal domain. J. Biol. Chem. 274:2113-2117.
24. Harkin, D. P., J. M. Bean, D. Miklos, Y. H. Song, V. B. Truong, C. Englert, F. C. Christians, L. W. Ellisen, S. Maheswaran, J. D. Oliner, and D. A. Haber. 1999. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97:575-586.
25. Hartman, A. R., and J. M. Ford. 2003. BRCA1 and p53: compensatory roles in DNA repair. J. Mol. Med.
26. Hartman, A. R., and J. M. Ford. 2002. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat. Genet. 32:180-184.
27. Horton, H. R., L. A. Moran, R. S. Ochs, J. D. Rawn, and K. G. Scrimgeour. 1994. (ed.) Principes de biochimie. DeBoeck Université ed., Brussels, Belgium.
28. Hu, Y. F., Z. L. Hao, and R. Li. 1999. Chromatin remodeling and activation of chromosomal DNA replication by an acidic transcriptional activation domain from BRCA1. Genes Dev. 13:637-642.
29. Inamoto, S., N. Segil, Z. Q. Pan, M. Kimura, and R. G. Roeder. 1997. The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors. J. Biol. Chem. 272:29852-29858.
30. Ko, L. J., S. Y. Shieh, X. Chen, L. Jayaraman, K. Tamai, Y. Taya, C. Prives, and Z. Q. Pan. 1997. p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner. Mol. Cell. Biol. 17:7220-7229.
31. Komarnitsky, P., E. J. Cho, and S. Buratowski. 2000. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev. 14:2452-2460.
32. Krum, S. A., G. A. Miranda, C. Lin, and T. F. Lane. 2003. BRCA1 associates with processive RNA polymerase II. J. Biol. Chem. 278:52012-52020.
33. Larochelle, S., J. Chen, R. Knights, J. Pandur, P. Morcillo, H. Erdjument-Bromage, P. Tempst, B. Suter, and R. P. Fisher. 2001. T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT1 complex in vivo and regulates its CTD kinase activity. EMBO J. 20:3749-3759.
34. Lee, T. I., and R. A. Young. 2000. Transcription of eukaryotic protein-coding genes. Annu. Rev. Genet. 34:77-137.
35. MacLachlan, T. K., K. Somasundaram, M. Sgagias, Y. Shifman, R. J. Muschel, K. H. Cowan, and W. S. El-Deiry. 2000. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J. Biol. Chem. 275:2777-2785.
36. Mallouk, Y., M. Vayssier-Taussat, J. V. Bonventre, and B. S. Polla. 1999. Heat shock protein 70 and ATP as partners in cell homeostasis. Int. J. Mol. Med. 4:463-474.
37. Manke, I. A., D. M. Lowery, A. Nguyen, and M. B. Yaffe. 2003. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302:636-639.
38. Marshall, N. F., and D. H. Price. 1995. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270:12335-12338.
39. Monteiro, A. N. 2002. Participation of BRCA1 in the DNA repair response via transcription. Cancer Biol. Ther. 1:187-188.
40. Monteiro, A. N., A. August, and H. Hanafusa. 1996. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA 93:13595-13599.
41. Nadeau, G., N. Boufaied, A. Moisan, K. M. Lemieux, C. Cayanan, A. N. Monteiro, and L. Gaudreau. 2000. BRCA1 can stimulate gene transcription by a unique mechanism. EMBO Rep. 1:260-265.
42. O'Brien, K. A., S. J. Lemke, K. S. Cocke, R. N. Rao, and R. P. Beckmann. 1999. Casein kinase 2 binds to and phosphorylates BRCA1. Biochem. Biophys. Res. Commun. 260:658-664.
43. Oelgeschlager, T. 2002. Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control. J. Cell Physiol. 190:160-169.
44. Ohkuma, Y., S. Hashimoto, C. K. Wang, M. Horikoshi, and R. G. Roeder. 1995. Analysis of the role of TFIIE in basal transcription and TFIIH-mediated carboxy-terminal domain phosphorylation through structure-function studies of TFIIE-α. Mol. Cell. Biol. 15:4856-4866.
45. Okamoto, T., S. Yamamoto, Y. Watanabe, T. Ohta, F. Hanaoka, R. G. Roeder, and Y. Ohkuma. 1998. Analysis of the role of TFIIE in transcriptional regulation through structure-function studies of the TFIIEbeta subunit. J. Biol. Chem. 273:19866-19876.
46. Paull, T. T., D. Cortex, B. Bowers, S. J. Elledge, and M. Geliert. 2001. Direct DNA binding by Brca1. Proc. Natl. Acad. Sci. USA 98:6086-6091.
47. Ptashne, M., and A. Gann. 1997. Transcriptional activation by recruitment. Nature 386:569-577.
48. Ratner, J. N., B. Balasubramanian, J. Corden, S. L. Warren, and D. B. Bregman. 1998. Ultraviolet radiation-induced ubiquitination and proteasomal degradation of the large subunit of RNA polymerase II. Implications for transcription-coupled DNA repair. J. Biol. Chem. 273:5184-5189.
49. Rickert, P., J. L. Corden, and E. Lees. 1999. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases. Oncogene 18:1093-1102.
50. Rossignol, M., I. Kolb-Cheynel, and J. M. Egly. 1997. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH. EMBO J. 16:1628-1637.
51. Scully, R., S. F. Anderson, D. M. Chao, W. Wei, L. Ye, R. A. Young, D. M. Livingston, and J. D. Parvin. 1997. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. USA 94:5605-5610.
52. Solomon, M. J., J. W. Harper, and J. Shuttleworth. 1993. CAK, the p34cdc2 activating kinase, contains a protein identical or closely related to p40MO15. EMBO J. 12:3133-3142.
53. Somasundaram, K. 2003. Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair-perhaps through transcription. J. Cell Biochem. 88:1084-1091.
54. Somasundaram, K., H. Zhang, Y. X. Zeng, Y. Houvras, Y. Peng, G. S. Wu, J. D. Licht, B. L. Weber, and W. S. El-Deiry. 1997. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389:187-190.
55. Sun, X., Y. Zhang, H. Cho, P. Rickert, E. Lees, W. Lane, and D. Reinberg. 1998. NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription. Mol. Cell 2:213-222.
56. Talukder, A. H., S. K. Mishra, M. Mandal, S. Balasenthil, S. Mehta, A. A. Sahin, C. J. Barnes, and R. Kumar. 2003. MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions. J. Biol. Chem. 278:11676-11685.
57. Wallenfang, M. R., and G. Seydoux. 2002. cdk-7 is required for mRNA transcription and cell cycle progression in Caenorhabditis elegans embryos. Proc. Natl. Acad. Sci. USA 99:5527-5532.
58. Welcsh, P. L., M. K. Lee, R. M. Gonzalez-Hernandez, D. J. Black, M. Mahadevappa, E. M. Swisher, J. A. Warrington, and M. C. King. 2002. BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc. Natl. Acad. Sci. USA 99:7560-7565.
59. Whitmarsh, A. J., and R. J. Davis. 2001. Analyzing JNK and p38 mitogen-activated protein kinase activity. Methods Enzymol. 332:319-336.
60. Williams, R. S., D. Chasman, D. Hau, B. Hui, A. Lau, and J. N. Glover. 2003. Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations. J. Biol. Chem. 278:53007-53016.
61. Williams, R. S., R. Green, and J. N. Glover. 2001. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Nat. Struct. Biol. 8:838-842.
62. Williamson, E. A., F. Dadmanesh, and H. P. Koeffler. 2002. BRCA1 transactivates the cyclin-dependent kinase inhibitor p27(Kip1). Oncogene 21:3199-3206.
63. Xu, X., T. Nakano, S. Wick, M. Dubay, and L. Brizuela. 1999. Mechanism of Cdk2/Cyclin E inhibition by p27 and p27 phosphorylation. Biochemistry 38:8713-8722.
64. Yamane, K., and T. Tsuruo. 1999. Conserved BRCT regions of TopBP1 and of the tumor suppressor BRCA1 bind strand breaks and termini of DNA. Oncogene 18:5194-5203.
65. Yankulov, K. Y., and D. L. Bentley. 1997. Regulation of CDK7 substrate specificity by MAT1 and TFIIH. EMBO J. 16:1638-1646.
66. Yu, X., C. C. Chini, M. He, G. Mer, and J. Chen. 2003. The BRCT domain is a phospho-protein binding domain. Science 302:639-642.
67. Yudkovsky, N., J. A. Ranish, and S. Hahn. 2000. A transcription reinitiation intermediate that is stabilized by activator. Nature 408:225-229.
68. Zawel, L., H. Lu, L. J. Cisek, J. L. Corden, and O. Reinberg. 1993. The cycling of RNA polymerase II during transcription. Cold Spring Harbor Symp. Quant. Biol. 58:187-198.
69. Zhang, J., and J. L. Corden. 1991. Phosphorylation causes a conformational change in the carboxyl-terminal domain of the mouse RNA polymerase II largest subunit. J. Biol. Chem. 266:2297-2302.